Document Detail


Macrophages expressing heme oxygenase-1 improve renal function in ischemia/reperfusion injury.
MedLine Citation:
PMID:  20551909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute kidney injury has a high mortality and lacks specific therapies, with ischemia/reperfusion injury (IRI) being the predominant cause. Macrophages (M phi) have been used successfully in cell therapy to deliver targeted therapeutic genes in models of inflammatory kidney disease. Heme oxygenase-1 (HO-1) catalyzes heme breakdown and has important cytoprotective functions. We hypothesized that administration of M phi modified to overexpress HO-1 would protect from renal IRI. Using an adenoviral construct (Ad-HO-1), HO-1 was overexpressed in primary bone marrow-derived M phi (BMDM). In vitro Ad-HO-1 M phi showed an anti-inflammatory phenotype with increased phagocytosis of apoptotic cells (ACs) and increased interleukin (IL)-10 but reduced TNF-alpha and nitric oxide (NO) following lipopolysaccharide/interferon-gamma (IFN gamma) stimulation compared to control transduced or unmodified M phi. In vivo, intravenously (IV) injected M phi homed preferentially to the post-IRI kidney compared to uninjured control following experimental IRI. At 24 hours postinjury, despite equivalent levels of tubular necrosis, apoptosis, and capillary density between groups, the injection of Ad-HO-1 M phi resulted in preserved renal function (serum creatinine reduced by 46%), and reduced microvascular platelet deposition. These data demonstrate that genetically modified M phi improve the outcomes in IRI when administered after the establishment of structural injury, raising the prospect of targeted cell therapy to support the function of the acutely injured kidney.
Authors:
David A Ferenbach; Vasudev Ramdas; Nishrin Spencer; Lorna Marson; Ignacio Anegon; Jeremy Hughes; David C Kluth
Related Documents :
8743459 - Roles of the mesangium in glomerular function.
19713309 - Mmp9 limits apoptosis and stimulates branching morphogenesis during kidney development.
10074479 - Angiotensin ii plays a pathogenic role in immune-mediated renal injury in mice.
16127149 - Lipoxin a4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression...
11053479 - Glomerular monocyte-macrophage features in anca-positive renal vasculitis and cryoglobu...
15004199 - Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of mrl/mp...
12419219 - Grb2 is a key mediator of helicobacter pylori caga protein activities.
10193439 - Asthma, viruses, and nitric oxide.
22105779 - Inhibition of hsp90 attenuates pro-inflammatory cytokines and prevents lps induced live...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-15
Journal Detail:
Title:  Molecular therapy : the journal of the American Society of Gene Therapy     Volume:  18     ISSN:  1525-0024     ISO Abbreviation:  Mol. Ther.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2010-12-22     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  100890581     Medline TA:  Mol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1706-13     Citation Subset:  IM    
Affiliation:
MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK. dferenbach@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoviridae / genetics
Animals
Apoptosis / genetics,  physiology
Blotting, Western
Fluorescent Antibody Technique
Heme Oxygenase-1 / genetics,  metabolism*
Immunohistochemistry
Injections, Intravenous
Interferon-gamma / pharmacology
Interleukin-10 / metabolism
Macrophages / drug effects,  metabolism*,  physiology
Male
Mice
Reperfusion Injury / genetics,  metabolism*,  therapy*
Tissue Therapy / methods*
Tumor Necrosis Factor-alpha / metabolism
Grant Support
ID/Acronym/Agency:
G0801235(87702)//Medical Research Council
Chemical
Reg. No./Substance:
0/Tumor Necrosis Factor-alpha; 130068-27-8/Interleukin-10; 82115-62-6/Interferon-gamma; EC 1.14.99.3/Heme Oxygenase-1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisen...
Next Document:  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5...